Physician profile
Elie Chbeir
NPI 1063553303
$8,272.78
in general payments reported to CMS, 2019-2025
32 companies · $1,328 in 2025
The $1,328 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $287 · 2020: $358 · 2021: $379 · 2022: $851 · 2023: $4,492 · 2024: $580 · 2025: $1,328.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $3,000 · Food and Beverage: $2,522 · Travel and Lodging: $877.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $3,000.00 |
| Food and Beverage | $2,522.13 |
| Travel and Lodging | $877.21 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,723.48 | 2023 | Ion, Da Vinci Surgical System |
| Astrazeneca Pharmaceuticals LP | $1,186.43 | 2019-2025 | Tezspire, Airsupra, Fasenra |
| Glaxosmithkline, LLC. | $784.27 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Pulmonx Corporation | $395.32 | 2025 | Zephyr Endobronchial Valve, Chartis Catheter, Pulmonx Chartis Tablet Console |
| Boehringer Ingelheim Pharmaceuticals, INC. | $253.50 | 2019-2025 | Spiriva Respimat, Ofev, Jascayd |
| Jazz Pharmaceuticals INC. | $226.79 | 2019-2025 | |
| Insmed, INC. | $226.50 | 2022-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $204.78 | 2019-2022 | |
| Mylan Specialty L.P. | $164.82 | 2019-2024 | Yupelri |
| Inspire Medical Systems, INC. | $149.15 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $139.34 | 2021-2025 | Dupixent |
| Genzyme Corporation | $121.95 | 2021-2025 | |
| Electromed, INC. | $121.71 | 2022-2025 | Smartvest |
| Erbe USA INC | $75.47 | 2023 | |
| United Therapeutics Corporation | $74.95 | 2022-2025 | Tyvaso, Tyvaso |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $58.66 | 2022-2025 | Tezspire |
| Grifols USA, LLC | $47.57 | 2022-2025 | Prolastin-C Liquid |
| Harmony Biosciences LLC | $39.09 | 2020-2021 | |
| Circassia INC. | $29.42 | 2019 | |
| Philips North America LLC | $27.76 | 2020-2022 | |
| Allergan, INC. | $27.73 | 2020 | |
| Welch Allyn | $24.38 | 2021 | |
| Shionogi INC | $22.50 | 2025 | Fetroja |
| Itamar Medical INC | $20.43 | 2023 | Watchpatone |
| Viatris Specialty LLC | $18.80 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $18.02 | 2023 | |
| Verona Pharma, INC. | $16.69 | 2025 | Ohtuvayre |
| Baxter Healthcare | $16.52 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Shire North American Group INC | $15.80 | 2019 | |
| Genentech USA, INC. | $14.84 | 2023 | Xolair |
| Mallinckrodt Hospital Products INC. | $13.58 | 2022 | |
| Nabriva Therapeutics, Plc | $12.53 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elie Chbeir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.